Omega-3 Probe Underscores FTC Standard For Claims Substantiation
This article was originally published in The Tan Sheet
Executive Summary
FTC's widespread review of omega-3 fatty acid supplement claims reminds firms they must support claims with "competent and reliable scientific evidence," a standard stakeholders argue is unclear and at times impractical
You may also be interested in...
J&J Woes, Pharma Switch Outlook Lead "The Tan Sheet" 2010 Topics
Quality control problems for Johnson & Johnson's McNeil Consumer Healthcare business and the regulatory and congressional scrutiny that followed dominated the attention of drug and dietary supplement industry stakeholders in 2010.
NBTY Agrees To $2.1M Settlement With FTC For False DHA Claims
The Federal Trade Commission's ongoing crackdown on "bogus" health claims leads to a $2.1 million settlement with NBTY and two subsidiaries to resolve charges they overstated the amount and benefit of DHA in children's multivitamins.
Despite FTC's "Timid" Kellogg Action, Rigorous Claims Enforcement Expected
The Federal Trade Commission's enforcement against advertising claims for Kellogg's Rice Krispies cereal appears relatively soft, but dietary supplement firms should not expect the action signals a less stringent approach by the agency, industry stakeholders say